Software - Application
Compare Stocks
4 / 10Stock Comparison
DBD vs FISV vs FIS vs JKHY
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
DBD vs FISV vs FIS vs JKHY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $2.75B | $30.38B | $24.47B | $10.57B |
| Revenue (TTM) | $3.86B | $21.09B | $10.89B | $2.52B |
| Net Income (TTM) | $110M | $3.20B | $382M | $519M |
| Gross Margin | 26.0% | 60.8% | 38.1% | 44.1% |
| Operating Margin | 8.0% | 24.4% | 17.5% | 26.0% |
| Forward P/E | 14.4x | 7.0x | 7.5x | 21.8x |
| Total Debt | $1.17B | $29.12B | $4.01B | $0.00 |
| Cash & Equiv. | $387M | $798M | $599M | $102M |
DBD vs FISV vs FIS vs JKHY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 23 | May 26 | Return |
|---|---|---|---|
| Diebold Nixdorf, In… (DBD) | 100 | 442.8 | +342.8% |
| Fiserv, Inc. (FISV) | 100 | 46.8 | -53.2% |
| Fidelity National I… (FIS) | 100 | 84.6 | -15.4% |
| Jack Henry & Associ… (JKHY) | 100 | 93.1 | -6.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DBD vs FISV vs FIS vs JKHY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DBD is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 289.1% 10Y total return vs JKHY's 94.9%
- +79.3% vs FISV's -68.8%
FISV is the clearest fit if your priority is valuation efficiency.
- PEG 0.20 vs JKHY's 2.16
- Lower P/E (7.0x vs 21.8x), PEG 0.20 vs 2.16
FIS is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.76, yield 3.5%
- Lower volatility, beta 0.76, Low D/E 28.9%, current ratio 0.59x
- 3.5% yield, 1-year raise streak, vs JKHY's 1.5%, (2 stocks pay no dividend)
JKHY carries the broadest edge in this set and is the clearest fit for growth exposure and defensive.
- Rev growth 7.2%, EPS growth 19.3%, 3Y rev CAGR 6.9%
- Beta 0.28, yield 1.5%, current ratio 1.27x
- 7.2% revenue growth vs DBD's 1.5%
- 20.6% margin vs DBD's 2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.2% revenue growth vs DBD's 1.5% | |
| Value | Lower P/E (7.0x vs 21.8x), PEG 0.20 vs 2.16 | |
| Quality / Margins | 20.6% margin vs DBD's 2.8% | |
| Stability / Safety | Beta 0.28 vs DBD's 1.21 | |
| Dividends | 3.5% yield, 1-year raise streak, vs JKHY's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +79.3% vs FISV's -68.8% | |
| Efficiency (ROA) | 17.0% ROA vs FIS's 1.1%, ROIC 21.0% vs 6.0% |
DBD vs FISV vs FIS vs JKHY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DBD vs FISV vs FIS vs JKHY — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JKHY leads in 2 of 6 categories
FISV leads 1 • DBD leads 1 • FIS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JKHY leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FISV is the larger business by revenue, generating $21.1B annually — 8.4x JKHY's $2.5B. JKHY is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to DBD's 2.8%. On growth, JKHY holds the edge at +8.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.9B | $21.1B | $10.9B | $2.5B |
| EBITDAEarnings before interest/tax | $400M | $7.5B | $3.8B | $810M |
| Net IncomeAfter-tax profit | $110M | $3.2B | $382M | $519M |
| Free Cash FlowCash after capex | $266M | $4.0B | $2.8B | $728M |
| Gross MarginGross profit ÷ Revenue | +26.0% | +60.8% | +38.1% | +44.1% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +24.4% | +17.5% | +26.0% |
| Net MarginNet income ÷ Revenue | +2.8% | +15.2% | +3.5% | +20.6% |
| FCF MarginFCF ÷ Revenue | +6.9% | +19.0% | +26.1% | +28.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.0% | -2.0% | +8.2% | +8.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +163.6% | -29.1% | +92.3% | +12.5% |
Valuation Metrics
FISV leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 9.0x trailing earnings, FISV trades at a 86% valuation discount to FIS's 63.0x P/E. Adjusting for growth (PEG ratio), FISV offers better value at 0.25x vs FIS's 2.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.7B | $30.4B | $24.5B | $10.6B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $58.7B | $27.9B | $10.5B |
| Trailing P/EPrice ÷ TTM EPS | 31.05x | 8.96x | 63.00x | 23.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.37x | 7.01x | 7.54x | 21.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.25x | 2.58x | 2.32x |
| EV / EBITDAEnterprise value multiple | 7.64x | 6.63x | 7.66x | 13.53x |
| Price / SalesMarket cap ÷ Revenue | 0.72x | 1.43x | 2.29x | 4.45x |
| Price / BookPrice ÷ Book value/share | 2.66x | 1.21x | 1.76x | 5.01x |
| Price / FCFMarket cap ÷ FCF | 10.43x | 7.00x | 9.97x | 17.97x |
Profitability & Efficiency
JKHY leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
JKHY delivers a 24.0% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $3 for FIS. FIS carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to FISV's 1.13x. On the Piotroski fundamental quality scale (0–9), DBD scores 6/9 vs FISV's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.1% | +12.4% | +2.7% | +24.0% |
| ROA (TTM)Return on assets | +2.9% | +4.0% | +1.1% | +17.0% |
| ROICReturn on invested capital | +14.0% | +8.1% | +6.0% | +21.0% |
| ROCEReturn on capital employed | +14.1% | +10.2% | +6.6% | +22.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.06x | 1.13x | 0.29x | — |
| Net DebtTotal debt minus cash | $787M | $28.3B | $3.4B | -$102M |
| Cash & Equiv.Liquid assets | $387M | $798M | $599M | $102M |
| Total DebtShort + long-term debt | $1.2B | $29.1B | $4.0B | $0 |
| Interest CoverageEBIT ÷ Interest expense | 6.68x | 6.39x | 4.64x | 122.37x |
Total Returns (Dividends Reinvested)
DBD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBD five years ago would be worth $38,342 today (with dividends reinvested), compared to $3,685 for FIS. Over the past 12 months, DBD leads with a +79.3% total return vs FISV's -68.8%. The 3-year compound annual growth rate (CAGR) favors DBD at 56.5% vs FISV's -22.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.3% | -13.4% | -27.3% | -17.8% |
| 1-Year ReturnPast 12 months | +79.3% | -68.8% | -35.3% | -13.6% |
| 3-Year ReturnCumulative with dividends | +283.4% | -52.5% | -6.6% | -1.0% |
| 5-Year ReturnCumulative with dividends | +283.4% | -51.7% | -63.2% | +0.3% |
| 10-Year ReturnCumulative with dividends | +289.1% | +9.7% | -13.2% | +94.9% |
| CAGR (3Y)Annualised 3-year return | +56.5% | -22.0% | -2.2% | -0.3% |
Risk & Volatility
Evenly matched — DBD and JKHY each lead in 1 of 2 comparable metrics.
Risk & Volatility
JKHY is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than DBD's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBD currently trades 88.6% from its 52-week high vs FISV's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.21x | 0.94x | 0.76x | 0.28x |
| 52-Week HighHighest price in past year | $89.05 | $191.91 | $82.74 | $193.39 |
| 52-Week LowLowest price in past year | $43.61 | $52.91 | $43.30 | $141.81 |
| % of 52W HighCurrent price vs 52-week peak | +88.6% | +29.6% | +57.1% | +75.5% |
| RSI (14)Momentum oscillator 0–100 | 47.4 | 36.5 | 43.3 | 28.2 |
| Avg Volume (50D)Average daily shares traded | 460K | 5.3M | 5.5M | 902K |
Analyst Outlook
Evenly matched — FIS and JKHY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DBD as "Buy", FISV as "Buy", FIS as "Buy", JKHY as "Buy". Consensus price targets imply 42.6% upside for FIS (target: $67) vs 26.8% for DBD (target: $100). For income investors, FIS offers the higher dividend yield at 3.45% vs JKHY's 1.54%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $100.00 | $74.64 | $67.38 | $203.75 |
| # AnalystsCovering analysts | 13 | 60 | 37 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.5% | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | — | 1 | 32 |
| Dividend / ShareAnnual DPS | — | — | $1.63 | $2.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.8% | +19.4% | 0.0% | +0.3% |
JKHY leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FISV leads in 1 (Valuation Metrics). 2 tied.
DBD vs FISV vs FIS vs JKHY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DBD or FISV or FIS or JKHY a better buy right now?
For growth investors, Jack Henry & Associates, Inc.
(JKHY) is the stronger pick with 7. 2% revenue growth year-over-year, versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). Fiserv, Inc. (FISV) offers the better valuation at 9. 0x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Diebold Nixdorf, Incorporated (DBD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DBD or FISV or FIS or JKHY?
On trailing P/E, Fiserv, Inc.
(FISV) is the cheapest at 9. 0x versus Fidelity National Information Services, Inc. at 63. 0x. On forward P/E, Fiserv, Inc. is actually cheaper at 7. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fiserv, Inc. wins at 0. 20x versus Jack Henry & Associates, Inc. 's 2. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DBD or FISV or FIS or JKHY?
Over the past 5 years, Diebold Nixdorf, Incorporated (DBD) delivered a total return of +283.
4%, compared to -63. 2% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: DBD returned +289. 1% versus FIS's -13. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DBD or FISV or FIS or JKHY?
By beta (market sensitivity over 5 years), Jack Henry & Associates, Inc.
(JKHY) is the lower-risk stock at 0. 28β versus Diebold Nixdorf, Incorporated's 1. 21β — meaning DBD is approximately 328% more volatile than JKHY relative to the S&P 500. On balance sheet safety, Fidelity National Information Services, Inc. (FIS) carries a lower debt/equity ratio of 29% versus 113% for Fiserv, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DBD or FISV or FIS or JKHY?
By revenue growth (latest reported year), Jack Henry & Associates, Inc.
(JKHY) is pulling ahead at 7. 2% versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). On earnings-per-share growth, the picture is similar: Diebold Nixdorf, Incorporated grew EPS 677. 3% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Over a 3-year CAGR, JKHY leads at 6. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DBD or FISV or FIS or JKHY?
Jack Henry & Associates, Inc.
(JKHY) is the more profitable company, earning 19. 2% net margin versus 2. 5% for Diebold Nixdorf, Incorporated — meaning it keeps 19. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FISV leads at 26. 9% versus 8. 8% for DBD. At the gross margin level — before operating expenses — FISV leads at 59. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DBD or FISV or FIS or JKHY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fiserv, Inc. (FISV) is the more undervalued stock at a PEG of 0. 20x versus Jack Henry & Associates, Inc. 's 2. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Fiserv, Inc. (FISV) trades at 7. 0x forward P/E versus 21. 8x for Jack Henry & Associates, Inc. — 14. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 42. 6% to $67. 38.
08Which pays a better dividend — DBD or FISV or FIS or JKHY?
In this comparison, FIS (3.
5% yield), JKHY (1. 5% yield) pay a dividend. DBD, FISV do not pay a meaningful dividend and should not be held primarily for income.
09Is DBD or FISV or FIS or JKHY better for a retirement portfolio?
For long-horizon retirement investors, Jack Henry & Associates, Inc.
(JKHY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 28), 1. 5% yield). Both have compounded well over 10 years (JKHY: +94. 9%, DBD: +289. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DBD and FISV and FIS and JKHY?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DBD is a small-cap quality compounder stock; FISV is a mid-cap deep-value stock; FIS is a mid-cap income-oriented stock; JKHY is a mid-cap quality compounder stock. FIS, JKHY pay a dividend while DBD, FISV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.